Vanderbilt University Has $6.02 Million Position in Danaher Corporation $DHR

Vanderbilt University cut its holdings in Danaher Corporation (NYSE:DHR) by 30.9% during the first quarter, according to its most recent Form 13F filing with the SEC. The firm owned 31,767 shares of the conglomerate’s stock after selling 14,238 shares during the period. Danaher accounts for approximately 1.1% of Vanderbilt University’s portfolio, making the stock its 15th biggest holding. Vanderbilt University’s holdings in Danaher were worth $6,023,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in DHR. Norges Bank acquired a new position in shares of Danaher during the fourth quarter worth approximately $2,177,106,000. Viking Global Investors LP grew its stake in shares of Danaher by 543.9% in the second quarter. Viking Global Investors LP now owns 2,907,515 shares of the conglomerate’s stock worth $574,351,000 after acquiring an additional 2,455,994 shares during the last quarter. Massachusetts Financial Services Co. MA increased its position in Danaher by 104.7% during the fourth quarter. Massachusetts Financial Services Co. MA now owns 4,333,056 shares of the conglomerate’s stock worth $991,923,000 after acquiring an additional 2,216,789 shares during the period. Wellington Management Group LLP increased its position in Danaher by 11.2% during the fourth quarter. Wellington Management Group LLP now owns 15,076,796 shares of the conglomerate’s stock worth $3,451,380,000 after acquiring an additional 1,517,904 shares during the period. Finally, Capital International Investors raised its stake in Danaher by 8.9% during the 4th quarter. Capital International Investors now owns 18,246,008 shares of the conglomerate’s stock valued at $4,177,386,000 after purchasing an additional 1,487,768 shares during the last quarter. Institutional investors and hedge funds own 79.05% of the company’s stock.

Danaher Stock Up 5.5%

DHR opened at $188.78 on Thursday. The company has a market capitalization of $133.61 billion, a P/E ratio of 36.51, a P/E/G ratio of 2.28 and a beta of 0.81. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.87 and a quick ratio of 1.52. The firm’s fifty day moving average price is $178.97 and its two-hundred day moving average price is $201.96. Danaher Corporation has a fifty-two week low of $160.93 and a fifty-two week high of $242.80.

Danaher (NYSE:DHR) last announced its quarterly earnings data on Monday, April 20th. The conglomerate reported $2.06 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.94 by $0.12. The company had revenue of $5.95 billion during the quarter, compared to analysts’ expectations of $6 billion. Danaher had a net margin of 14.89% and a return on equity of 10.91%. The business’s revenue was up 3.7% on a year-over-year basis. During the same quarter in the prior year, the company posted $1.88 EPS. On average, analysts anticipate that Danaher Corporation will post 8.45 EPS for the current year.

Danaher Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, July 31st. Investors of record on Friday, June 26th will be paid a $0.40 dividend. The ex-dividend date of this dividend is Friday, June 26th. This represents a $1.60 dividend on an annualized basis and a yield of 0.8%. Danaher’s payout ratio is presently 30.95%.

Wall Street Analysts Forecast Growth

A number of analysts have weighed in on the stock. HSBC reduced their price target on shares of Danaher from $270.00 to $230.00 and set a “buy” rating for the company in a report on Wednesday, June 3rd. Royal Bank Of Canada assumed coverage on shares of Danaher in a research report on Thursday, May 14th. They set an “outperform” rating and a $200.00 price objective for the company. TD Cowen reduced their target price on shares of Danaher from $245.00 to $240.00 and set a “buy” rating for the company in a research note on Wednesday, April 22nd. Morgan Stanley decreased their target price on Danaher from $270.00 to $255.00 and set an “overweight” rating on the stock in a research report on Wednesday, April 22nd. Finally, Rothschild & Co Redburn set a $205.00 price target on Danaher in a research note on Friday, April 17th. One equities research analyst has rated the stock with a Strong Buy rating, nineteen have issued a Buy rating and five have issued a Hold rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $233.61.

Danaher Company Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.